Data from a Phase 3 study has revealed that ivonescimab demonstrates a statistically significant and clinically meaningful improvement in progression-free survival compared to pembrolizumab for patients with PD-L1-positive ...
Sep 8, 2024
0
0
New data presented today reveals that the PanCan nodule management protocol demonstrates superior performance in triaging lung cancer screening participants compared to the LungRADSv1.1 approach. Specifically, PanCan showed ...
Sep 8, 2024
0
0
New data presented today demonstrate that TROP2 expression as measured by quantitative continuous scoring (QCS), a computational pathology approach, is a promising predictor of clinical outcomes in patients with advanced ...
Sep 8, 2024
0
0
People with operable non-small cell lung cancers may fare better over the next few years by receiving immunotherapy treatments before and after surgery instead of only before surgery, according to a new analysis by Johns ...
Sep 8, 2024
0
0
New data from landmark analysis presented today reports a decreased risk of disease recurrence or death in patients with resectable NSCLC who received adjuvant nivolumab following neoadjuvant nivolumab plus chemotherapy and ...
Sep 8, 2024
0
0
U.S. cancer incidence trends improved in 2021, but continued to be lower than expected, according to a study published online Sept. 6 in JAMA Network Open.
Sep 8, 2024
0
0
The risk for lung cancer is high in patients with rheumatoid arthritis (RA) and pulmonary complications, according to a study published online Sept. 3 in Modern Rheumatology.
Sep 8, 2024
0
0
As a new federal regulation that requires mammography centers to tell their patients how dense their breasts are takes effect, experts explain what breast density is and why it is important.
Sep 8, 2024
0
0
A systematic review into the potential health effects from radio wave exposure has shown mobile phones are not linked to brain cancer. The review was commissioned by the World Health Organization and is published today in ...
Sep 7, 2024
0
4
A study presented today at the International Association for the Study of Lung Cancer 2024 World Conference on Lung Cancer demonstrates a promising pathway toward developing predictive biomarkers for immune checkpoint inhibitors.
Sep 7, 2024
0
0
